Quadracel Market Report 2026

Quadracel Market Overview

• The Quadracel market growth in the historic period has been driven by expansion of national immunization programs, improved vaccine manufacturing capabilities • Market expansion is supported by increasing focus on global vaccination coverage, rising investments in pediatric vaccine development • Growth Driver: Increasing Incidence Of Vaccine-Preventable Diseases Drives Growth In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Quadracel Market?

Quadracel is a combination vaccine used to immunize children aged 4 to 6 years against diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis. It contains inactivated poliovirus and acellular pertussis components, ensuring safety and effectiveness. Approved for routine pediatric vaccination, it simplifies immunization schedules by combining multiple antigens in a single dose. The main types of quadracel are the DTaP-IPV vaccine and combination vaccines. The DTaP-IPV vaccine is a combination immunization that protects against diphtheria, tetanus, pertussis (whooping cough), and polio, typically administered to children. It is indicated for diphtheria, tetanus, pertussis (whooping cough), and poliomyelitis (polio). Quadracel is used in pediatric vaccination, adult vaccination, traveler vaccination programs, and healthcare workers vaccinations and is used by several end users such as hospitals, clinics, vaccination centers, government health programs, and private healthcare providers.

What Is The Quadracel Market Growth Forecast?

The growth in the forecast period can be attributed to increasing focus on global vaccination coverage, rising investments in pediatric vaccine development, expansion of government-backed immunization initiatives, growing demand for combination vaccines, advancements in vaccine formulation technologies. Major trends in the forecast period include increasing adoption of combination pediatric vaccines, rising focus on immunization schedule simplification, growing emphasis on vaccine safety and efficacy, expansion of routine childhood vaccination programs, enhanced cold-chain vaccine distribution.

Global Quadracel Market Segmentation

1) By Type: DTaP-IPV Vaccine, Combination Vaccines 2) By Indication: Diphtheria, Tetanus, Pertussis (Whooping Cough), Poliomyelitis (Polio) 3) By Application: Pediatric Vaccination, Adult Vaccination, Traveler Vaccination Programs, Healthcare Workers Vaccination 4) By End User: Hospitals, Clinics, Vaccination Centers, Government Health Programs, Private Healthcare Providers

What Are The Drivers Of The Quadracel Market?

The increasing incidence of vaccine-preventable diseases is expected to boost the growth of the quadracel market going forward. Vaccine-preventable diseases (VPDs) refer to infectious diseases for which effective vaccines are available to prevent illness, complications, and fatalities. The increasing incidence of vaccine-preventable diseases (VPDs) is a concerning public health issue influenced by several factors, including gaps in vaccination coverage, evolving pathogens, and societal challenges. Quadracel is an important vaccine that provides protection against multiple vaccine-preventable diseases in a single shot. It helps reduce the burden of these illnesses, improving public health outcomes. For instance, in August 2024, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the increasing incidence of vaccine-preventable diseases is driving the growth of the quadracel industry. The increasing prevalence of infectious diseases is expected to propel the growth of the quadracel market going forward. Infectious diseases refer to illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that invade the body and multiply, leading to symptoms and potentially severe health complications. The increasing prevalence of infectious diseases is attributed to several factors, including antimicrobial resistance (AMR), globalization and urbanization, climate change, and inadequate vaccination coverage. Quadracel is effective in combating infectious diseases by offering a combination vaccine that protects against four significant infections diphtheria, tetanus, pertussis, and polio. For instance, in December 2024, the Centers for Disease Control and Prevention, a US-based national public health agency, reported pertussis cases in the United States increased more than sixfold by week 47 (November 30, 2024) compared to the same period in 2023, reflecting a return to typical trends. Therefore, the increasing prevalence of infectious diseases is driving the growth of the quadracel industry. The increasing government initiatives are expected to boost the growth of the quadracel market going forward. The increasing government initiatives are attributed to several factors, including growing public health concerns, rising healthcare costs, global health challenges, and public demand for better healthcare services. Government initiatives are essential in promoting quadracel by ensuring its availability, affordability, and widespread vaccination to prevent multiple infectious diseases. For instance, in May 2024, according to the data published by the United States Department of Health and Human Services (HHS), a US-based government principal agency for protecting health, the President’s Fiscal Year 2024 Budget aims to advance the Department of Health and Human Services' mission of promoting the health and well-being of Americans. For FY 2024, HHS has proposed $144.3 billion in discretionary budget authority and $1.7 trillion in mandatory funding, reflecting an increase from the FY 2022 proposal of $131.8 billion in discretionary and $1.5 trillion in mandatory funding. Therefore, the increasing government initiatives are boosting the growth of the quadracel industry.

Key Players In The Global Quadracel Market

Major companies operating in the quadracel market are Sanofi Pasteur Limited

Regional Insights

North America was the largest region in the quadracel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Quadracel Market?

The quadracel market consists of sales of products such as combination vaccines and single-dose vaccines. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Quadracel Market Report 2026?

The quadracel market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the quadracel industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.